Cargando…
_version_ 1784801885629186048
author Beccacece, Alessia
Ascoli Bartoli, Tommaso
Nicastri, Emanuele
author_facet Beccacece, Alessia
Ascoli Bartoli, Tommaso
Nicastri, Emanuele
author_sort Beccacece, Alessia
collection PubMed
description
format Online
Article
Text
id pubmed-9531359
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-95313592022-10-04 Re: Remdesivir for the treatment of COVID-19 by Lee et al. Beccacece, Alessia Ascoli Bartoli, Tommaso Nicastri, Emanuele Clin Microbiol Infect Letter to the Editor European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2023-01 2022-10-04 /pmc/articles/PMC9531359/ /pubmed/36206865 http://dx.doi.org/10.1016/j.cmi.2022.09.015 Text en © 2022 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Beccacece, Alessia
Ascoli Bartoli, Tommaso
Nicastri, Emanuele
Re: Remdesivir for the treatment of COVID-19 by Lee et al.
title Re: Remdesivir for the treatment of COVID-19 by Lee et al.
title_full Re: Remdesivir for the treatment of COVID-19 by Lee et al.
title_fullStr Re: Remdesivir for the treatment of COVID-19 by Lee et al.
title_full_unstemmed Re: Remdesivir for the treatment of COVID-19 by Lee et al.
title_short Re: Remdesivir for the treatment of COVID-19 by Lee et al.
title_sort re: remdesivir for the treatment of covid-19 by lee et al.
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531359/
https://www.ncbi.nlm.nih.gov/pubmed/36206865
http://dx.doi.org/10.1016/j.cmi.2022.09.015
work_keys_str_mv AT beccacecealessia reremdesivirforthetreatmentofcovid19byleeetal
AT ascolibartolitommaso reremdesivirforthetreatmentofcovid19byleeetal
AT nicastriemanuele reremdesivirforthetreatmentofcovid19byleeetal